Sitavig FDA Approval History
FDA Approved: Yes (First approved April 12, 2013)
Brand name: Sitavig
Generic name: acyclovir
Dosage form: Buccal Tablets
Company: BioAlliance Pharma SA
Treatment for: Cold Sores
Sitavig (acyclovir) is a mucoadhesive buccal tablet formulation of the antiviral drug acyclovir indicated for the treatment of recurrent orofacial herpes (cold sores).
Development timeline for Sitavig
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
